Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Department of Neurosurgery, Loma Linda University, Loma Linda, CA, USA.
J Cereb Blood Flow Metab. 2022 Apr;42(4):543-558. doi: 10.1177/0271678X211045748. Epub 2021 Nov 22.
Knowledge about the dynamic metabolism and function of cerebrospinal fluid (CSF) physiology has rapidly progressed in recent decades. It has traditionally been suggested that CSF is produced by the choroid plexus and drains to the arachnoid villi. However, recent findings have revealed that the brain parenchyma produces a large portion of CSF and drains through the perivascular glymphatic system and meningeal lymphatic vessels into the blood. The primary function of CSF is not limited to maintaining physiological CNS homeostasis but also participates in clearing waste products resulting from neurodegenerative diseases and acute brain injury. Aneurysmal subarachnoid hemorrhage (SAH), a disastrous subtype of acute brain injury, is associated with high mortality and morbidity. Post-SAH complications contribute to the poor outcomes associated with SAH. Recently, abnormal CSF flow was suggested to play an essential role in the post-SAH pathophysiological changes, such as increased intracerebral pressure, brain edema formation, hydrocephalus, and delayed blood clearance. An in-depth understanding of CSF dynamics in post-SAH events would shed light on potential development of SAH treatment options. This review summarizes and updates the latest physiological characteristics of CSF dynamics and discusses potential pathophysiological changes and therapeutic targets after SAH.
近年来,人们对脑脊液(CSF)生理学的动态代谢和功能有了快速的了解。传统上认为,CSF 是由脉络丛产生的,并通过蛛网膜绒毛排出。然而,最近的发现表明,脑实质产生了大量的 CSF,并通过血管周隙神经胶质系统和脑膜淋巴管进入血液。CSF 的主要功能不仅限于维持中枢神经系统的生理稳态,还参与清除神经退行性疾病和急性脑损伤产生的废物。蛛网膜下腔出血(SAH)是一种灾难性的急性脑损伤亚型,与高死亡率和高发病率相关。SAH 后的并发症是导致 SAH 预后不良的原因之一。最近,异常的 CSF 流动被认为在 SAH 后的病理生理变化中起着重要作用,如颅内压升高、脑水肿形成、脑积水和延迟血液清除。深入了解 SAH 后 CSF 动力学将为潜在的 SAH 治疗方案的开发提供思路。本文综述了 CSF 动力学的最新生理特征,并讨论了 SAH 后可能的病理生理变化和治疗靶点。